Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-934P is a non-coding RNA pseudogene homologous to the U6 small nuclear RNA locus. U6 snRNA is a highly conserved, functional component of the spliceosome complex, crucial for catalyzing intron removal from pre-mRNAs in eukaryotes[1][3]. Numerous U6 snRNA pseudogenes, including RNU6-934P, are scattered throughout the genome and generally lack function or expression[2][5]. Pseudogenes are genomic DNA sequences resembling functional genes but containing defects—such as insertions, deletions, or point mutations—that preclude normal transcription or processing[5]. Thus, RNU6-934P does not participate in splicing, gene regulation, or any recognized cellular or disease-related processes. If you require details on the functional U6 small nuclear RNA (U6 snRNA), that molecule is essential for mRNA splicing as part of the spliceosome[1][3]. However, the "934 pseudogene" is just one of many nonfunctional, gene-like copies lacking biological activity or therapeutic relevance[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 934, pseudogene (RNU6-934P).